The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Serabi Gold PLC
OTC:SRBIF
|
UK |
|
Curis Inc
NASDAQ:CRIS
|
US |
|
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
|
TR |
|
H
|
Hongkong and Shanghai Hotels Ltd
OTC:HKSHF
|
HK |
|
O
|
Origin Agritech Ltd
F:39O1
|
CN |
|
X
|
Xenon Pharmaceuticals Inc
SWB:XP0
|
CA |
|
Wynnstay Group PLC
LSE:WYN
|
UK |
|
E
|
Ebro Foods SA
DUS:AZU
|
ES |
|
A
|
Adx Energy Ltd
SWB:GHU
|
AU |
|
H
|
Hongkong and Shanghai Hotels Ltd
F:HSG
|
HK |
|
E
|
Edison International
DUS:EIX
|
US |
|
Grupo Ezentis SA
F:RDT1
|
ES |
|
C
|
China Gas Holdings Ltd
SWB:EBZ
|
HK |
|
Diamond Fields Resources Inc
XTSX:DFR
|
CA |
|
N
|
Novo Nordisk A/S
SWB:NOVA
|
DK |
|
B
|
BEACN Wizardry & Magic Inc
XTSX:BECN
|
CA |
|
Tekmar Group PLC
F:6UA
|
UK |
|
S
|
SeA Mechanics Co Ltd
KOSDAQ:396300
|
KR |
|
N
|
Niraj Cement Structurals Ltd
BSE:532986
|
IN |
|
Buccaneer Energy PLC
LSE:BUCE
|
UK |
Serabi Gold PLC (SRBIF)’s 12-month stock price forecast through October 2027 has a consensus target of $5.508, implying 115% upside. The forecast is based on price targets from 6 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
SRBIF is 5.508 USD with a low forecast of 4.909 USD and a high forecast of 8.278 USD.
The compound annual growth rate for Revenue over the next 5 years is 9%.
The compound annual growth rate for Gross Profit over the next 3 years is 17%.
The compound annual growth rate for Operating Income over the next 5 years is 3%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is 23%.
The compound annual growth rate for Net Income over the next 5 years is -1%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more